DekaBank Deutsche Girozentrale’s ANI Pharmaceuticals ANIP Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,022	Closed	-$1.67M	–	1119
2025 Q4	$1.67M	Hold	23,022	–	–	﹤0.01%	798
2025 Q3	$2.07M	Hold	23,022	–	–	﹤0.01%	741
2025 Q2	$1.49M	Hold	23,022	–	–	﹤0.01%	800
2025 Q1	$1.52M	Hold	23,022	–	–	﹤0.01%	778
2024 Q4	$1.22M	Hold	23,022	–	–	﹤0.01%	837
2024 Q3	$1.32M	Hold	23,022	–	–	﹤0.01%	835
2024 Q2	$1.44M	Hold	23,022	–	–	﹤0.01%	817
2024 Q1	$1.57M	Hold	23,022	–	–	﹤0.01%	801
2023 Q4	$1.25M	Hold	23,022	–	–	﹤0.01%	861
2023 Q3	$1.34M	Buy	23,022 +3,022	+15%	+$174K	﹤0.01%	823
2023 Q2	$1.06M	Buy	20,000 +10,000	+100%	+$443K	﹤0.01%	865
2023 Q1	$389K	Hold	10,000	–	–	﹤0.01%	1060
2022 Q4	$408K	Buy	+10,000	New	+$376K	﹤0.01%	1078
2021 Q4	–	Sell	-3,450	Closed	-$115K	–	1421
2021 Q3	$115K	Hold	3,450	–	–	﹤0.01%	1287
2021 Q2	$112K	Hold	3,450	–	–	﹤0.01%	1318
2021 Q1	$113K	Hold	3,450	–	–	﹤0.01%	1274
2020 Q4	$97K	Hold	3,450	–	–	﹤0.01%	1277
2020 Q3	$96K	Buy	+3,450	New	+$103K	﹤0.01%	1132

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ANIP Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 23,022 shares — an estimated $1.67M sold.

DekaBank Deutsche Girozentrale first reported a position in ANIP in Q3 2020 and held it in 18 quarters. The position peaked at $2.07M in Q3 2025. 281 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 23,022 ANI Pharmaceuticals shares in Q1 2026, an estimated $1.67M.
DekaBank Deutsche Girozentrale first reported a position in ANI Pharmaceuticals in Q3 2020 and held it in 18 quarters.
DekaBank Deutsche Girozentrale's ANI Pharmaceuticals position peaked at $2.07M in Q3 2025.
281 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.